The Trump administration plans to end the 2006 Unapproved Drug Initiative (UDI); this closes a loophole that cost billions annually and led to shortages. Many pharmaceuticals used today entered the market before 1938, the year the FDA implemented safety reviews. UDI required manufacturers to pull these drugs and prove their safety to the FDA. The first company to gain approval of a previously unapproved drug could earn up to seven years of patent protection. This led to “artificial monopolies” and drug shortages, according to Health and Human Services. For example, five old, essential drugs have been approved through the UDI in recent years, leading to 1,644% price hikes, according to Vizient analysis. (Modern Healthcare
CMS added more than 60 telehealth services that will be reimbursable during the public health emergency. Those changes to telehealth coverage will also be allowed permanently in rural areas. CMS added several services to category one, which includes services similar to office visits or psychiatry services and consultations. Services added include group psychotherapy, home visits and psychological testing. It also added services to category three, including emergency department visits, therapy services and hospital discharge day management. Those changes are permanent in rural areas. Any other permanent changes elsewhere require Congressional action. (Fierce Healthcare
Note: sources that have an asterisk require login to view the article.
TODAY December 15, 2020 | 2:00 – 3:00pm EST
Jared Augenstein, MA, MPH, director, Manatt, Phelps & Phillips, LLP, to present to the GTMRx Payment and Policy Solutions Workgroup
. The following are the key subjects that will be addressed:
- Value telehealth will bring to the provider, patient and payer
- How COVID-19 will change CMM care
- Actions the government can take to improve availability and adoptability of telehealth
If you are interested in attending this presentation, please reach out to GTMRx Operations Manager, Izzy Serji, MPH, at firstname.lastname@example.org
, with the subject line “GTMRx Speaker: 12/15”
The Get The Medications Right Institute (GTMRx) workgroups
have developed a set of Tools from Our Experts
to advocate for medication management reform
. These tools are designed to be useful resources for all stakeholders, and we believe these will be vital to optimize medication use through CMM in practice. We encourage you to share them, post them and use them to advocate for medication management reform. Get a sneak peek at these guidance documents here
. (Note: In January, website enhancements will include a sortable feature.)
The GTMRx’s Precision Medicine Enablement via Advanced Diagnostics Workgroup and Pharmacogenomics Payment and Policy Taskforce recently completed an evidence document
that articulates the value of pharmacogenomics in the context of comprehensive medication management. In this blog post, Jill S. Bates, PharmD, MS, BCOP, FASHP. National PHASER pharmacy program manager for the Department of Veterans Affairs, offers insights into what the task force learned. Read it here
In a just released episode, GTMRx executive director Katie Capps
appeared on GenXy’s Precision Insights Podcast
. The series consists of inspiring conversations around precision medicine with industry thought leaders and innovators where they share the most cutting-edge technologies, processes and initiatives in precision and personalized medicine. ?Katie discussed some common myths around CMM, how it differs from MTM, how PGx can be used to optimize medication and how we can integrate PGx into the CMM process to reap genomic and personalized medicine’s full benefits. Be sure to listen? here.
AmazonSmile is an easy way for 0.5% of your qualified purchases go to the GTMRx Foundation at no cost to you. And signing up is simple—go to smile.amazon.com
and select “Get the Medications Right Foundation” as your charity of choice. If you prefer to directly donate instead, you can do so here
Adding the foundation on AmazonSmile will help us continue to provide no cost educational webinars, issue briefs, weekly news briefs and promote the need for transformation of our current system of medication use through social media campaigns.
See past issues of our weekly news brief here.